March 17, 2021 3 min read Opinions expressed by
Entrepreneur contributors are their own.
As the vaccination campaign to end the coronavirus pandemic rages on, XPRIZE, an organization holding million-dollar competitions continues to incentivize innovation and development to better the world. Their most recent contest, “$6M XPRIZE Rapid COVID Testing”, aimed to create game-changing COVID-19 testing solutions and named several winners.
One of the Open Innovation Track winners was TERA (TeraGroup), an Israeli company utilizing “Terahertz (THz)” waves technology, to produce a 1-3-minutes coronavirus breath test, named the BioSafety test. This simple and rapid BioSafety clearance test is meant to determine if an individual is Negative for COVID-19 and Clear to proceed.
Grand Prize Winners Selected in $6M XPRIZE Rapid Covid Testing Competition to Create Fast, Frequent, Cheap, and Easy-to-Use Solutions
Dr. Rick Bright, Ph.D., Immunology and Molecular Pathogenesis
Shawna Butler, R.N. M.D.A., Nurse Economist
Dr. Charity Dean, CEO and Co-Founder, The Public Health Company
Dr. Paul Drain, Associate Professor, Departments of Global Health, Medicine and Epidemiology at the University of Washington
Dr. Anita Goel, Physicist and Physician, Chairman and CEO, Nanobiosym
Dr. Michael Mina, Physician-Scientist and Assistant Professor, Epidemiology and Immunology and Infectious Diseases at the Harvard School of Public Health
Dr. Anne Wyllie, Associate Research Scientist, Yale School of Public Health
SALT LAKE CITY A University of Utah electrical and computer engineering professor has been named a finalist for prize money in an international competition to develop innovations in rapid testing for COVID-19.
Massood Tabib-Azar s rapid test is a small electronic device that can detect the presence of SARS-CoV-2 through a user s breath or a drop of saliva and delivers results in less than a minute.
Tabib-Azar is one of 10 finalists in the Open Innovation Track for the XPRIZE Rapid COVID Testing competition. The rapid testing contest has a track for tests that utilize PCR, antigen detection and other traditional methods, while the Open Innovation Track is for nontraditional tests whose approaches demonstrated high potential for impactful screening solutions, the XPRIZE website says.
COVID-19 crisis: Mumbai team develops algorithm that tests more patients with fewer trials, awaits approval Tapestry Pooling, the initiative developed by the team from Mumbai, is today a finalist in the Open Innovation Track of the $500,000 XPRIZE, a worldwide COVID-19 testing competition Apekshita Varshney / CitizenMatters.in January 11, 2021 20:04:29 IST
About five years ago, Manoj Gopalkrishnan, a professor at the Indian Institute of Technology (IIT) Bombay, heard about the Middle East Respiratory Syndrome coronavirus or MERS-COV outbreak.
He read news stories discussing the shortage of testing kits and wondered if pooling as a form of testing, where samples are mixed together in a batch and only tested further if the combined sample tests positive, could be used to accelerate testing.